Mkts

Cytek Biosciences, Inc.

NASDAQ: CTKB
$5.94+0.24 (+4.21%)
As of Nov 18, 11:34 AM ET

Key statistics

Day range
5.625.97
52-week range
3.316.33
Today
Open5.63
Previous close5.94
Volume—
Valuation
Market cap745.47M
P/E ratio—
EPS (TTM)-0.63
Income & risk
Dividend / yield—
Beta1.22
Avg volume1.14M
Discussion

CTKB News

Stories mentioning CTKB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue44,13562,14152,29345,60241,45757,47651,50046,617
Cost of Goods Sold22,88129,25624,74221,73521,30023,82422,49521,181
Gross Profit21,25432,88527,55123,86720,15733,65229,00525,436
Operating Expenses
Research & Development9,6048,9618,9568,8269,7259,7239,88210,001
Sales General & Admin
Total Operating Expenses39,71738,47836,74334,49135,13230,66633,25333,963
Operating Income (Loss)(18,463)(5,593)(9,192)(10,624)(14,975)2,986(4,248)(8,527)
Interest Income787.00580.00573.00555.00508.00913.001,4331,416
Interest Expense
Other Expense565.00257.001,3443,7083,492490.003,09159.00
Pretax Income(4,031)(7,769)(6,775)(11,266)10,322157.00(7,186)
Tax Provision1,49340,045(2,291)(1,192)136.00680.00(784.00)3,248
Net Income (Loss)(18,866)(11,402)
Earnings Per Share (Basic)0.000.00
Earnings Per Share (Diluted)0.000.00
Weighted Average Shares Outstanding (Basic)128,705127,746127,548126,934128,339130,611131,004131,440
Weighted Average Shares Outstanding (Diluted)128,705127,746127,548126,934128,339130,611132,786131,440

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CTKB

Cytek Biosciences, Inc. (NASDAQ: CTKB) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTKB. It last traded at $5.94 (Nov 18, 2026, 11:34 AM ET), up 4.2% on the day. That gives Cytek Biosciences a market capitalisation of $745.5M.

Over the past 52 weeks CTKB has traded between $3.31 and $6.33.

Revenue for the quarter ended Mar 31, 2026 was $44.1M; a net loss of $18.9M. Revenue was up 6.5% from $41.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$44.1M-$18.9M-42.7%
Dec 31, 2025$62.1M——
Sep 30, 2025$52.3M——
Jun 30, 2025$45.6M——

From Cytek Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…